Infection/inflammation-associated preterm delivery within 14 days of presentation with symptoms of preterm labour: A multivariate predictive model
Autoři:
Emmanuel Amabebe aff001; Steven Reynolds aff002; Xiaoya He aff001; Robyn Wood aff001; Victoria Stern aff001; Dilly O. C. Anumba aff001
Působiště autorů:
Academic Unit of Reproductive and Developmental Medicine, University of Sheffield, Sheffield, England, United Kingdom
aff001; Academic Unit of Radiology, University of Sheffield, Sheffield, England, United Kingdom
aff002
Vyšlo v časopise:
PLoS ONE 14(9)
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pone.0222455
Souhrn
Multi-marker tests hold promise for identifying symptomatic women at risk of imminent preterm delivery (PTD, <37 week’s gestation). This study sought to determine the relationship of inflammatory mediators and metabolites in cervicovaginal fluid (CVF) with spontaneous PTD (sPTD) and delivery within 14 days of presentation with symptoms of preterm labour (PTL). CVF samples from 94 (preterm = 19, term = 75) singleton women with symptoms of PTL studied between 19+0–36+6 weeks’ gestation were analysed for cytokines/chemokines by multiplexed bead-based immunoassay, while metabolites were quantified by enzyme-based spectrophotometry in a subset of 61 women (preterm = 16, term = 45). Prevalence of targeted vaginal bacterial species was determined for 70 women (preterm = 14, term = 66) by PCR. Overall, 10 women delivered within 14 days of sampling. Predictive capacities of individual biomarkers and cytokine-metabolite combinations for sPTD and delivery within 14 days of sampling were analysed by logistic regression models and area under the receiver operating characteristic curve. Fusobacterium sp., Mubiluncus mulieris and Mycoplasma hominis were detected in more preterm-delivered than term women (P<0.0001), while, M. curtisii was found in more term-delivered than preterm women (P<0.0001). RANTES (0.91, 0.65–1.0), IL-6 (0.79, 0.67–0.88), and Acetate/Glutamate ratio (0.74, 0.61–0.85) were associated with delivery within 14 days of sampling (AUC, 95% CI). There were significant correlations between cytokines and metabolites, and several cytokine-metabolite combinations were associated with sPTD or delivery within 14 days of sampling (e.g. L/D-lactate ratio+Acetate/Glutamate ratio+IL-6: 0.84, 0.67–0.94). Symptomatic women destined to deliver preterm and within 14 days of sampling express significantly higher pro-inflammatory mediators at mid to late gestation. In this cohort, IL-6, Acetate/Glutamate ratio and RANTES were associated with delivery within 14 days of sampling, consistent with their roles in modulating infection-inflammation-associated preterm labour in women presenting with symptoms of preterm birth. Replication of these observations in larger cohorts of women could show potential clinical utility.
Klíčová slova:
Biology and life sciences – Biochemistry – Organisms – Research and analysis methods – Enzymology – Neuroscience – Developmental biology – Medicine and health sciences – Microbiology – Medical microbiology – Microbial pathogens – Bacterial pathogens – Bacteria – Pathology and laboratory medicine – Pathogens – Physiology – Women's health – Maternal health – Birth – Obstetrics and gynecology – Pregnancy – Immunology – Immune system – Innate immune system – Cytokines – Immune physiology – Molecular development – Metabolism – Carbohydrate metabolism – Glucose metabolism – Spectrum analysis techniques – Spectrophotometry – Neurochemistry – Gut bacteria – Neurotransmitters – Glutamate – Metabolites – Enzyme chemistry – Enzyme metabolism – Fusobacteria – Preterm birth – Pregnancy complications
Zdroje
1. Bianchi-Jassir F, Seale AC, Kohli-Lynch M, Lawn JE, Baker CJ, Bartlett L, et al. Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2017;65(Suppl 2):S133–S42. doi: 10.1093/cid/cix661 PMC5850429. 29117329
2. Goldenberg RL, Culhane JF, Iams JD, Romero R. Preterm birth 1—Epidemiology and causes of preterm birth. Lancet. 2008;371(9606):75–84. doi: 10.1016/S0140-6736(08)60074-4 WOS:000252192600033. 18177778
3. Tsiartas P, Holst R, Wennerholm U, Hagberg H, Hougaard D, Skogstrand K, et al. Prediction of spontaneous preterm delivery in women with threatened preterm labour: a prospective cohort study of multiple proteins in maternal serum. BJOG: An International Journal of Obstetrics & Gynaecology. 2012;119(7):866–73.
4. Goldenberg RL. The management of preterm labor. Obstetrics & Gynecology. 2002;100(5, Part 1):1020–37.
5. Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Accuracy of cervicovaginal fetal fibronectin test in predicting risk of spontaneous preterm birth: systematic review. British Medical Journal. 2002;325(7359):301–4C. doi: 10.1136/bmj.325.7359.301 WOS:000177482500015. 12169504
6. Ramsey PS, Andrews WW. Biochemical predictors of preterm labor: fetal fibronectin and salivary estriol. Clinics in perinatology. 2003;30(4):701–33. 14714920
7. Heng YJ, Liong S, Permezel M, Rice GE, Di Quinzio MK, Georgiou HM. Human cervicovaginal fluid biomarkers to predict term and preterm labor. Frontiers in physiology. 2015;6.
8. Liong S, Di Quinzio M, Fleming G, Permezel M, Rice G, Georgiou H. New biomarkers for the prediction of spontaneous preterm labour in symptomatic pregnant women: a comparison with fetal fibronectin. BJOG: An International Journal of Obstetrics & Gynaecology. 2015;122(3):370–9.
9. Amabebe E, Reynolds S, Stern VL, Parker JL, Stafford GP, Paley MN, et al. Identifying metabolite markers for preterm birth in cervicovaginal fluid by magnetic resonance spectroscopy. Metabolomics. 2016;12(4):1–11.
10. Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba DOC. Cervicovaginal Fluid Acetate: A Metabolite Marker of Preterm Birth in Symptomatic Pregnant Women. Frontiers in Medicine. 2016;3(48). doi: 10.3389/fmed.2016.00048 27777928
11. Srinivasan S, Morgan MT, Fiedler TL, Djukovic D, Hoffman NG, Raftery D, et al. Metabolic Signatures of Bacterial Vaginosis. mBio. 2015;6(2):e00204–15. doi: 10.1128/mBio.00204-15 25873373
12. Lamont RF. Advances in the Prevention of Infection-Related Preterm Birth. Frontiers in immunology. 2015;6(566). doi: 10.3389/fimmu.2015.00566 26635788
13. Nelson DB, Hanlon A, Nachamkin I, Haggerty C, Mastrogiannis DS, Liu C, et al. Early Pregnancy Changes in Bacterial Vaginosis‐Associated Bacteria and Preterm Delivery. Paediatric and perinatal epidemiology. 2014;28(2):88–96. doi: 10.1111/ppe.12106 24405280
14. Foxman B, Wen A, Srinivasan U, Goldberg D, Marrs CF, Owen J, et al. Mycoplasma, bacterial vaginosis-associated bacteria BVAB3, race, and risk of preterm birth in a high-risk cohort. American journal of obstetrics and gynecology. 2014;210(3):226.e1–.e2267. Epub 2013/10/04. doi: 10.1016/j.ajog.2013.10.003 24096128.
15. Amabebe E, Chapman DR, Stern VL, Stafford G, Anumba DOC. Mid-gestational changes in cervicovaginal fluid cytokine levels in asymptomatic pregnant women are predictive markers of inflammation-associated spontaneous preterm birth. Journal of Reproductive Immunology. 2018;126:1–10. doi: 10.1016/j.jri.2018.01.001 29367099
16. Chan RL. Biochemical markers of spontaneous preterm birth in asymptomatic women. BioMed research international. 2014;2014.
17. Georgiou HM, Di Quinzio MK, Permezel M, Brennecke SP. Predicting Preterm Labour: Current Status and Future Prospects. Disease markers. 2015;2015:435014. Epub 2015/07/15. doi: 10.1155/2015/435014 26160993; PubMed Central PMCID: PMC4486247.
18. Amabebe E. Analysis of cervicovaginal fluid metabolome and microbiome in relation to preterm birth [PhD thesis]. White Rose eTheses Online: University of Sheffield; 2016.
19. Stafford GP, Parker JL, Amabebe E, Kistler J, Reynolds S, Stern V, et al. Spontaneous Preterm Birth Is Associated with Differential Expression of Vaginal Metabolites by Lactobacilli-Dominated Microflora. Frontiers in Physiology. 2017;8(615). doi: 10.3389/fphys.2017.00615 28878691
20. Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba D. Prognostic Capacity of Cervicovaginal Fluid Acetate-Glutamate Ratio for Risk of Preterm Delivery within Two Weeks of Presentation with Symptoms of Preterm Labor. Reproductive Sciences. 2017;24:175A-A. WOS:000399043900390.
21. Bernhard AE, Field KG. A PCR assay To discriminate human and ruminant feces on the basis of host differences in Bacteroides-Prevotella genes encoding 16S rRNA. Applied and environmental microbiology. 2000;66(10):4571–4. Epub 2000/09/30. doi: 10.1128/aem.66.10.4571-4574.2000 11010920; PubMed Central PMCID: PMC92346.
22. Ling Z, Kong J, Liu F, Zhu H, Chen X, Wang Y, et al. Molecular analysis of the diversity of vaginal microbiota associated with bacterial vaginosis. BMC genomics. 2010;11. doi: 10.1186/1471-2164-11-488 WOS:000282790600001. 20819230
23. Walter J, Margosch D, Hammes WP, Hertel C. Detection of Fusobacterium species in human feces using genus-specific PCR primers and denaturing gradient gel electrophoresis. Microbial Ecology in Health and Disease. 2002;14(3):129–32. doi: 10.1080/089106002320644294 BCI:BCI200300038741.
24. Zariffard MR, Saifuddin M, Sha BE, Spear GT. Detection of bacterial vaginosis-related organisms by real-time PCR for Lactobacilli, Gardnerella vaginalis and Mycoplasma hominis. FEMS immunology and medical microbiology. 2002;34(4):277–81. Epub 2002/11/22. doi: 10.1111/j.1574-695X.2002.tb00634.x 12443827.
25. Jacobsson B, Mattsby-Baltzer I, Hagberg H. Interleukin-6 and interleukin-8 in cervical and amniotic fluid: relationship to microbial invasion of the chorioamniotic membranes. 2005;112(6):719–24. doi: 10.1111/j.1471-0528.2005.00536.x 15924526
26. Witkin S, Linhares I. Why do lactobacilli dominate the human vaginal microbiota? 2017;124(4):606–11. doi: 10.1111/1471-0528.14390 28224747
27. Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. 2017;595(2):451–63. doi: 10.1113/JP271694 27373840
28. Vitali B, Cruciani F, Picone G, Parolin C, Donders G, Laghi L. Vaginal microbiome and metabolome highlight specific signatures of bacterial vaginosis. Eur J Clin Microbiol. 2015;34(12):2367–76.
29. Laghi L, Picone G, Cruciani F, Brigidi P, Calanni F, Donders G, et al. Rifaximin modulates the vaginal microbiome and metabolome in women affected by bacterial vaginosis. Antimicrobial agents and chemotherapy. 2014;58(6):3411–20. doi: 10.1128/AAC.02469-14 24709255
30. Aldunate M, Srbinovski D, Hearps AC, Latham CF, Ramsland PA, Gugasyan R, et al. Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis. Frontiers in physiology. 2015;6:164. doi: 10.3389/fphys.2015.00164 26082720
31. Amabebe E, Anumba DOC. The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. 2018;5(181). doi: 10.3389/fmed.2018.00181 29951482
32. Wolfgang Buckel HAB. Two Pathways of Glutamate Fermentation by Anaerobic Bacteria. Journal of Bacteriology. 1974;117 (3):1248–60. 4813895
33. Ramezani M, Resmer KL, White RL. Glutamate racemization and catabolism in Fusobacterium varium. The FEBS Journal. 2011;278(14):2540–51. doi: 10.1111/j.1742-4658.2011.08179.x 21575137
34. Gajer P, Brotman RM, Bai GY, Sakamoto J, Schuette UME, Zhong X, et al. Temporal Dynamics of the Human Vaginal Microbiota. Sci Transl Med. 2012;4(132). ARTN 132ra52 doi: 10.1126/scitranslmed.3003605 ISI:000303596400004. 22553250
35. Fanos V, Atzori L., Makarenko K., Melis G.B., Ferrazi E. Metabolomics application in maternal-fetal medicine. BioMed research international. 2013;2013(720514):http://dx.doi.org/10.1155/2013/720514.
36. Romero R, Mazaki-Tovi S., Vaisbuch E., Kusanovic J.P., Chaiworapongsa T., Gomez R., Nien J.K., Yoon B.H., Mazor M., Luo J., Banks D., Ryals J., Beecher C. Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery. J Matern Fetal Neonatal Med. 2010;23(12):1344–59. doi: 10.3109/14767058.2010.482618 20504069
37. Hamilton SA, Tower CL, Jones RL. Identification of Chemokines Associated with the Recruitment of Decidual Leukocytes in Human Labour: Potential Novel Targets for Preterm Labour. PLOS ONE. 2013;8(2):e56946. doi: 10.1371/journal.pone.0056946 23451115
38. Ghartey J, Bastek JA, Brown AG, Anglim L, Elovitz MA. Women with preterm birth have a distinct cervicovaginal metabolome. American Journal of Obstetrics and Gynecology. 2015;212(6):776. e1–.e12.
39. Chow SS, Craig ME, Jones CA, Hall B, Catteau J, Lloyd AR, et al. Differences in amniotic fluid and maternal serum cytokine levels in early midtrimester women without evidence of infection. Cytokine. 2008;44(1):78–84. Epub 2008/08/16. doi: 10.1016/j.cyto.2008.06.009 18703348.
40. Yang Q, El-Sayed Y, Rosenberg-Hasson Y, Hirschberg DL, Nayak NR, Schilling J, et al. Multiple cytokine profile in plasma and amniotic fluid in a mouse model of pre-term labor. Am J Reprod Immunol. 2009;62(5):339–47. Epub 2009/10/09. doi: 10.1111/j.1600-0897.2009.00743.x 19811468.
41. Athayde N, Romero R, Maymon E, Gomez R, Pacora P, Araneda H, et al. A role for the novel cytokine RANTES in pregnancy and parturition. American Journal of Obstetrics and Gynecology. 1999;181(4):989–94. doi: 10.1016/s0002-9378(99)70337-6 10521766
42. Vrachnis N, Karavolos S, Iliodromiti Z, Sifakis S, Siristatidis C, Mastorakos G, et al. Impact of mediators present in amniotic fluid on preterm labour. In Vivo. 2012;26(5):799–812. 22949593
43. Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Seminars in Fetal and Neonatal Medicine. 2012;17(1):12–9. doi: 10.1016/j.siny.2011.09.001 21944863
44. Keelan JA. Pharmacological inhibition of inflammatory pathways for the prevention of preterm birth. Journal of Reproductive Immunology. 2011;88(2):176–84. doi: 10.1016/j.jri.2010.11.003 21236496
45. Keelan JA. Intrauterine inflammatory activation, functional progesterone withdrawal, and the timing of term and preterm birth. Journal of Reproductive Immunology. 2018;125:89–99. doi: 10.1016/j.jri.2017.12.004 29329080
46. Kalinka J, Sobala W, Wasiela M, Brzezińska-Błaszczyk E. Decreased Proinflammatory Cytokines in Cervicovaginal Fluid, as Measured in Midgestation, are Associated with Preterm Delivery. American Journal of Reproductive Immunology. 2005;54(2):70–6. doi: 10.1111/j.1600-0897.2005.00289.x 16105098
47. Inglis SR, Jeremias J, Kuno K, Lescale K, Peeper Q, Chervenak FA, et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol. 1994;171(1):5–10. Epub 1994/07/01. doi: 10.1016/s0002-9378(94)70069-9 8030732.
48. Paternoster DM, Stella A, Gerace P, Manganelli F, Plebani M, Snijders D, et al. Biochemical markers for the prediction of spontaneous pre-term birth. 2002;79(2):123–9. doi: 10.1016/S0020-7292(02)00243-6
49. Lockwood CJ, Ghidini l, Wein R, Lapinski R, Casal D, Berkowitz RL. Increased interleukin-6 concentrations in cervical secretions are associated with preterm delivery. American Journal of Obstetrics and Gynecology. 1994;171(4):1097–102. doi: 10.1016/0002-9378(94)90043-4 7943078
50. Kalan AM, Simhan HN. Mid-trimester cervical inflammatory milieu and sonographic cervical length. American Journal of Obstetrics and Gynecology. 2010;203(2):126.e1–.e5. https://doi.org/10.1016/j.ajog.2010.03.013.
51. Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. The Journal of Physiology. 2016:n/a-n/a. doi: 10.1113/JP271694 27373840
52. Donders GG, Van Calsteren C, Bellen G, Reybrouck R, Van den Bosch T, Riphagen I, et al. Association between abnormal vaginal flora and cervical length as risk factors for preterm birth. Ultrasound in Obstetrics & Gynecology. 2010.
53. Agrawal V, Hirsch E, editors. Intrauterine infection and preterm labor. Seminars in Fetal and Neonatal Medicine; 2012: Elsevier.
54. Holst RM, Hagberg H, Wennerholm UB, Skogstrand K, Thorsen P, Jacobsson B. Prediction of spontaneous preterm delivery in women with preterm labor: analysis of multiple proteins in amniotic and cervical fluids. Obstet Gynecol. 2009;114(2 Pt 1):268–77. Epub 2009/07/23. doi: 10.1097/AOG.0b013e3181ae6a08 19622987.
55. Vogel I, Goepfert AR, Thorsen P, Skogstrand K, Hougaard DM, Curry AH, et al. Early second-trimester inflammatory markers and short cervical length and the risk of recurrent preterm birth. J Reprod Immunol. 2007;75(2):133–40. Epub 2007/04/20. doi: 10.1016/j.jri.2007.02.008 17442403.
56. Deshpande S, van Asselt A, Tomini F, Armstrong N, Allen A, Noake C, et al. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. 2013.
57. Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, Zamora J, Schlattmann P. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. American Journal of Obstetrics and Gynecology. 2014;210(1):54.e1–.e10. http://dx.doi.org/10.1016/j.ajog.2013.09.004.
Článok vyšiel v časopise
PLOS One
2019 Číslo 9
- Metamizol jako analgetikum první volby: kdy, pro koho, jak a proč?
- Nejasný stín na plicích – kazuistika
- Masturbační chování žen v ČR − dotazníková studie
- Těžké menstruační krvácení může značit poruchu krevní srážlivosti. Jaký management vyšetření a léčby je v takovém případě vhodný?
- Fixní kombinace paracetamol/kodein nabízí synergické analgetické účinky
Najčítanejšie v tomto čísle
- Graviola (Annona muricata) attenuates behavioural alterations and testicular oxidative stress induced by streptozotocin in diabetic rats
- CH(II), a cerebroprotein hydrolysate, exhibits potential neuro-protective effect on Alzheimer’s disease
- Comparison between Aptima Assays (Hologic) and the Allplex STI Essential Assay (Seegene) for the diagnosis of Sexually transmitted infections
- Assessment of glucose-6-phosphate dehydrogenase activity using CareStart G6PD rapid diagnostic test and associated genetic variants in Plasmodium vivax malaria endemic setting in Mauritania